Compile Data Set for Download or QSAR
Found 23 of ic50 data for polymerid = 50006835
TargetUbiquitin carboxyl-terminal hydrolase isozyme L5(Homo sapiens (Human))
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538571(CHEMBL4635160)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human GST-tagged UCHL5 expressed in Escherichia coli assessed as cleavage of Ubiquitin-Rhodamine110-glycine to Ubiquitin and Rhodamine1...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase isozyme L5(Homo sapiens (Human))
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50072959(CHEMBL3410535)copy SMILEScopy InChI
Affinity DataIC50: 1.36E+4nMAssay Description:Inhibition of GST-tagged UCHL5 (unknown origin) using Ub-AMC as substrate preincubated for 30 mins before substrate addition measured after 60 mins b...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2J67JM0PubMed
TargetUbiquitin carboxyl-terminal hydrolase isozyme L5(Homo sapiens (Human))
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM65518(5-Chloro-1-[(2,5-dichlorophenyl)methyl]-1H-indole-...)copy SMILEScopy InChI
Affinity DataIC50: 1.62E+4nMpH: 7.5 T: 2°CAssay Description:Ubiquitin-7-amino-4-methylcoumarin (Ub-AMC) was generated as previously described.(7) The enzymatic reaction was conducted in fluorometric assay buff...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q21J97WDPubMed
TargetUbiquitin carboxyl-terminal hydrolase isozyme L5(Homo sapiens (Human))
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50242207(CHEMBL455364 | Mangiferin)copy SMILEScopy InChI
Affinity DataIC50: 3.00E+4nMpH: 7.5 T: 2°CAssay Description:Ubiquitin-7-amino-4-methylcoumarin (Ub-AMC) was generated as previously described.(7) The enzymatic reaction was conducted in fluorometric assay buff...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q21J97WDPubMed
TargetUbiquitin carboxyl-terminal hydrolase isozyme L5(Homo sapiens (Human))
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50552483(CHEMBL4763594)copy SMILES
Affinity DataIC50: 3.29E+4nMAssay Description:Inhibition of N-terminal His6-tagged recombinant human UCHL5 expressed in Escherichia coli BL21 (DE3) codon cells assessed as reduction in cleavage o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2R49VFDPubMed
TargetUbiquitin carboxyl-terminal hydrolase isozyme L5(Homo sapiens (Human))
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50442907(Acetyl Isogambogic Acid | CHEMBL3039433)copy SMILEScopy InChI
Affinity DataIC50: 3.65E+4nMpH: 7.5 T: 2°CAssay Description:Ubiquitin-7-amino-4-methylcoumarin (Ub-AMC) was generated as previously described.(7) The enzymatic reaction was conducted in fluorometric assay buff...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q21J97WDPubMed
TargetUbiquitin carboxyl-terminal hydrolase isozyme L5(Homo sapiens (Human))
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50072960(CHEMBL3410537)copy SMILEScopy InChI
Affinity DataIC50: 4.30E+4nMAssay Description:Inhibition of GST-tagged UCHL5 (unknown origin) using Ub-AMC as substrate preincubated for 30 mins before substrate addition measured after 60 mins b...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2J67JM0PubMed
TargetUbiquitin carboxyl-terminal hydrolase isozyme L5(Homo sapiens (Human))
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM205457((2R,4aS,6aR,6aS,14aS,14bR)-10-hydroxy-2,4a,6a,6a,9...)copy SMILEScopy InChI
Affinity DataIC50: 5.66E+4nMpH: 7.5 T: 2°CAssay Description:Ubiquitin-7-amino-4-methylcoumarin (Ub-AMC) was generated as previously described.(7) The enzymatic reaction was conducted in fluorometric assay buff...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q21J97WDPubMed
TargetUbiquitin carboxyl-terminal hydrolase isozyme L5(Homo sapiens (Human))
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM200235(Rifampicin | cid_5381226)copy SMILEScopy InChI
Affinity DataIC50: 6.28E+4nMpH: 7.5 T: 2°CAssay Description:Ubiquitin-7-amino-4-methylcoumarin (Ub-AMC) was generated as previously described.(7) The enzymatic reaction was conducted in fluorometric assay buff...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q21J97WDPubMed
TargetUbiquitin carboxyl-terminal hydrolase isozyme L5(Homo sapiens (Human))
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50552481(CHEMBL4761097)copy SMILES
Affinity DataIC50: 7.26E+4nMAssay Description:Inhibition of N-terminal His6-tagged recombinant human UCHL5 expressed in Escherichia coli BL21 (DE3) codon cells assessed as reduction in cleavage o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2R49VFDPubMed
TargetUbiquitin carboxyl-terminal hydrolase isozyme L5(Homo sapiens (Human))
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50552486(CHEMBL4785714)copy SMILES
Affinity DataIC50: 7.57E+4nMAssay Description:Inhibition of N-terminal His6-tagged recombinant human UCHL5 expressed in Escherichia coli BL21 (DE3) codon cells assessed as reduction in cleavage o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2R49VFDPubMed
TargetUbiquitin carboxyl-terminal hydrolase isozyme L5(Homo sapiens (Human))
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50552484(CHEMBL4787127)copy SMILES
Affinity DataIC50: 8.05E+4nMAssay Description:Inhibition of N-terminal His6-tagged recombinant human UCHL5 expressed in Escherichia coli BL21 (DE3) codon cells assessed as reduction in cleavage o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2R49VFDPubMed
TargetUbiquitin carboxyl-terminal hydrolase isozyme L5(Homo sapiens (Human))
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50552478(CHEMBL4795817)copy SMILES
Affinity DataIC50: 8.09E+4nMAssay Description:Inhibition of N-terminal His6-tagged recombinant human UCHL5 expressed in Escherichia coli BL21 (DE3) codon cells assessed as reduction in cleavage o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2R49VFDPubMed
TargetUbiquitin carboxyl-terminal hydrolase isozyme L5(Homo sapiens (Human))
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50552476(CHEMBL4747595)copy SMILES
Affinity DataIC50: 8.45E+4nMAssay Description:Inhibition of N-terminal His6-tagged recombinant human UCHL5 expressed in Escherichia coli BL21 (DE3) codon cells assessed as reduction in cleavage o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2R49VFDPubMed
TargetUbiquitin carboxyl-terminal hydrolase isozyme L5(Homo sapiens (Human))
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50552485(CHEMBL4741346)copy SMILES
Affinity DataIC50: 8.91E+4nMAssay Description:Inhibition of N-terminal His6-tagged recombinant human UCHL5 expressed in Escherichia coli BL21 (DE3) codon cells assessed as reduction in cleavage o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2R49VFDPubMed
TargetUbiquitin carboxyl-terminal hydrolase isozyme L5(Homo sapiens (Human))
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50552479(CHEMBL4745257)copy SMILES
Affinity DataIC50: 9.62E+4nMAssay Description:Inhibition of N-terminal His6-tagged recombinant human UCHL5 expressed in Escherichia coli BL21 (DE3) codon cells assessed as reduction in cleavage o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2R49VFDPubMed
TargetUbiquitin carboxyl-terminal hydrolase isozyme L5(Homo sapiens (Human))
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50069762(CHEMBL3182437 | ML323 | US9802904, 87)copy SMILEScopy InChI
Affinity DataIC50: 1.14E+5nMpH: 7.5 T: 2°CAssay Description:Ubiquitin-7-amino-4-methylcoumarin (Ub-AMC) was generated as previously described.(7) The enzymatic reaction was conducted in fluorometric assay buff...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q21J97WDPubMed
TargetUbiquitin carboxyl-terminal hydrolase isozyme L5(Homo sapiens (Human))
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM65524((-)-Aricine | Heterophylline (VAN) | Quinovatine)copy SMILEScopy InChI
Affinity DataIC50: 1.14E+5nMpH: 7.5 T: 2°CAssay Description:Ubiquitin-7-amino-4-methylcoumarin (Ub-AMC) was generated as previously described.(7) The enzymatic reaction was conducted in fluorometric assay buff...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q21J97WDPubMed
TargetUbiquitin carboxyl-terminal hydrolase isozyme L5(Homo sapiens (Human))
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50552475(CHEMBL4779271)copy SMILES
Affinity DataIC50: 1.16E+5nMAssay Description:Inhibition of N-terminal His6-tagged recombinant human UCHL5 expressed in Escherichia coli BL21 (DE3) codon cells assessed as reduction in cleavage o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2R49VFDPubMed
TargetUbiquitin carboxyl-terminal hydrolase isozyme L5(Homo sapiens (Human))
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50552477(CHEMBL4777141)copy SMILES
Affinity DataIC50: 2.15E+5nMAssay Description:Inhibition of N-terminal His6-tagged recombinant human UCHL5 expressed in Escherichia coli BL21 (DE3) codon cells assessed as reduction in cleavage o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2R49VFDPubMed
TargetUbiquitin carboxyl-terminal hydrolase isozyme L5(Homo sapiens (Human))
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50552480(CHEMBL4740091)copy SMILES
Affinity DataIC50: 2.52E+5nMAssay Description:Inhibition of N-terminal His6-tagged recombinant human UCHL5 expressed in Escherichia coli BL21 (DE3) codon cells assessed as reduction in cleavage o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2R49VFDPubMed
TargetUbiquitin carboxyl-terminal hydrolase isozyme L5(Homo sapiens (Human))
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50552482(CHEMBL4792819)copy SMILES
Affinity DataIC50: 2.85E+5nMAssay Description:Inhibition of N-terminal His6-tagged recombinant human UCHL5 expressed in Escherichia coli BL21 (DE3) codon cells assessed as reduction in cleavage o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2R49VFDPubMed
TargetUbiquitin carboxyl-terminal hydrolase isozyme L5(Homo sapiens (Human))
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM223313(Tiaprofenic acid)copy SMILEScopy InChI
Affinity DataIC50: 2.95E+6nMAssay Description:Inhibition of N-terminal His6-tagged recombinant human UCHL5 expressed in Escherichia coli BL21 (DE3) codon cells assessed as reduction in cleavage o...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2R49VFDPubMed